Table 1.
Sample characteristics and intervention measures
| Author | Year | N | Sex (m/f) |
Age (year) |
Diagnosis | Duration of medication(m) | Follow-up duration (m) | MINORS |
|---|---|---|---|---|---|---|---|---|
| Takaya et al. [9] | 2021 | 42 | 10/32 | 51 ± 18 | ASD | 9 | 33 | 12 |
| Thomaz et al. [10] | 2019 | 33 | 12/18 | 0.8(median) | VSD\PDA\A-V canal | 6 | 6 | 13 |
| Huang et al. [11] | 2011 | 38 | – | 3.04 ± 1.98 | ASD\VSD\PDA | 5-120 days | 117.6 | 12 |
| Hu et al. [12] | 2015 | 31 | 19/21 | 29.19 ± 8.51 | VSD | 7.29 | 37.9 | 12 |
| 8 | 3/5 | 22.75 ± 3.77 | VSD and ES | 12.38 | 31.50 | 12 | ||
| Kijima et al. [13] | 2015 | 8 | 0/8 | 37 ± 15 | ASD | – | 19 | 12 |
| Bradley et al. [14] | 2018 | 19 | 4/15 | 37 + 23 | ASD | 24 | 52.8 | 12 |
| Liu et al. [15] | 2014 | 56 | 25/31 | 17.2 ± 9.3 | VSD | 4.4 | 27.9 | 13 |
| He et al. [16] | 2020 | 14 | 1/13 | 27.9 ± 7.4 | ASD | 10.7 | 21.1 | 12 |
| Liu et al. [8] | 2010 | 86 | 51/35 | 2 ± 1.8 | d-TGA\TBA | 13.4 days | 42.1 | 12 |
m/f male/female, m month, ASD atrial septal defect, VSD ventricular septal defect, PDA patent ductus arteriosus, A-V canal atrioventricular septal defect, ES Eisenmenger syndrome, d-TGA dextrotransposition of the great arteries, TBA Taussig-Bing anomaly